SBP3500517
FREM2 Blocking Peptide for SAB3500517
Sign In to View Organizational & Contract Pricing.
About This Item
NACRES:
NA.41
UNSPSC Code:
12352203
biological source
synthetic
form
liquid
species reactivity
mouse, human
concentration
200 μg/mL
shipped in
wet ice
storage temp.
−20°C
Immunogen
19 amino acids near the carboxy terminus of human FREM2.
Application
Used as a blocking peptide in immunoblotting applications.
Other Notes
This peptide blocks the action of antibody SAB3500517.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
1 of 1
This Item | |||
|---|---|---|---|
| biological source synthetic | biological source synthetic | biological source synthetic | biological source synthetic |
| form liquid | form liquid | form liquid | form liquid |
| shipped in wet ice | shipped in wet ice | shipped in wet ice | shipped in wet ice |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| concentration 200 μg/mL | concentration 200 μg/mL | concentration 200 μg/mL | concentration 200 μg/mL |
| species reactivity mouse, human | species reactivity mouse, human, rat | species reactivity human, rat, mouse | species reactivity human, mouse |
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ivana Jovčevska et al.
Cancers, 11(8) (2019-07-31)
World Health Organization grade IV diffuse gliomas, known as glioblastomas, are the most common malignant brain tumors, and they show poor prognosis. Multimodal treatment of surgery followed by radiation and chemotherapy is not sufficient to increase patient survival, which is